Kintara Therapeutics received notice from Nasdaq that it was not in compliance with the minimum stockholders equity requirement, but regained compliance after selling shares of common stock.
AI Assistant
TUHURA BIOSCIENCES INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.